A Study to Assess Safety of Current Standard Malaria Treatment and an Assessment of G6PD Status in South-east Bangladesh
A Study to Assess Safety of Current Standard Malaria Treatment and an Assessment of Glucose-6-dehydrogenase Status in South-east Bangladesh
Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh
This PHASE4 trial investigates Malaria and is currently completed. International Centre for Diarrhoeal Disease Research, Bangladesh leads this study, which shows 11 recorded versions since 2014 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Apr 2024 — Jul 2024 [monthly]
Completed PHASE4
-
Jan 2023 — Apr 2024 [monthly]
Completed PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE4
▶ Show 6 earlier versions
-
Jun 2022 — Dec 2022 [monthly]
Completed PHASE4
-
Jan 2021 — Jun 2022 [monthly]
Completed PHASE4
-
Oct 2020 — Jan 2021 [monthly]
Completed PHASE4
-
Jun 2018 — Oct 2020 [monthly]
Completed PHASE4
-
Sep 2017 — Jun 2018 [monthly]
Completed PHASE4
-
Jan 2017 — Sep 2017 [monthly]
Completed PHASE4
First recorded
Aug 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- International Centre for Diarrhoeal Disease Research, Bangladesh
- Menzies School of Health Research
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.